Stock Analysis on Net

Altria Group Inc. (NYSE:MO)

$22.49

This company has been moved to the archive! The financial data has not been updated since October 31, 2024.

Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Liabilities represents obligations of a company arising from past events, the settlement of which is expected to result in an outflow of economic benefits from the entity.

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Altria Group Inc., consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)

US$ in millions

Microsoft Excel
Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Short-term borrowings
Current portion of long-term debt
Accounts payable
Marketing
Settlement charges
Other
Accrued liabilities
Deferred gain from the sale of IQOS System commercialization rights
Dividends payable
Liabilities held for sale
Current liabilities
Long-term debt, excluding current portion
Deferred income taxes
Accrued pension costs
Accrued postretirement health care costs
Deferred gain from the sale of IQOS System commercialization rights
Other liabilities
Non-current liabilities
Total liabilities
Redeemable noncontrolling interest
Common stock, par value $0.33 1/3 per share
Additional paid-in capital
Earnings reinvested in the business
Accumulated other comprehensive losses
Cost of repurchased stock
Stockholders’ equity (deficit) attributable to Altria
Noncontrolling interests
Total stockholders’ equity (deficit)
Total liabilities and stockholders’ equity (deficit)

Based on: 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31).


The analysis of the quarterly financial data reveals several notable trends and shifts in the company's financial position over the reported periods.

Short-term borrowings and Current portion of long-term debt
Short-term borrowings appear intermittently, with a notable borrowing of $3 billion in March 2020 and a reduced figure of $2 billion in the latter quarters of 2023. The current portion of long-term debt exhibits variability but generally maintains between approximately $1 billion and $2.6 billion, with some fluctuations observed particularly in 2022 and 2023.
Accounts payable and Accrued liabilities
Accounts payable shows an overall increasing trend, rising from $205 million in Q1 2019 to above $500 million by late 2023 and early 2024, indicating possibly increased operational activity or delayed payments. Accrued liabilities display volatility with spikes in early years and a general decline during mid-2021, followed by moderate recovery, suggesting changes in accrued expenses or accrued obligations dynamics.
Marketing and Settlement charges
Marketing expenditures steadily increase over the period, growing from $490 million in Q1 2019 to over $800 million by Q3 2024, reflecting increased investment in promotional activities. Settlement charges fluctuate significantly, with recurring peaks and troughs indicating episodic or transaction-based expenses. The highest levels are recorded in early and late 2019 and 2021, with notable declines during mid-2022 and 2024.
Other and Other liabilities
The ‘Other’ category shows marked volatility, peaking significantly in Q2 2020 at $3.5 billion but otherwise showing irregular fluctuations. Other liabilities generally increase toward the end of the period, particularly a sharp rise in 2022 and 2023 to well above prior levels, which may point to increasing miscellaneous or contingent obligations.
Deferred gain from the sale of IQOS System commercialization rights
This item is recorded starting in late 2022 at $2.7 billion consistently, suggesting recognition of a significant deferred revenue or gain component from the IQOS rights commercialization.
Dividends payable
Dividends payable remain relatively stable throughout, hovering near $1.5 billion to $1.7 billion, indicating consistent dividend policies and sustained shareholder returns.
Current liabilities and Total liabilities
Current liabilities exhibit strong volatility. They decline sharply in mid-2021, followed by a rise peaking in early 2023 at over $11.6 billion before tapering off later. Total liabilities broadly mirror these movements but demonstrate a gradual downward trend after peaking around late 2019 and early 2020, suggesting active management or reduction of overall obligations in recent quarters.
Long-term debt (excluding current portion)
Long-term debt remains high and relatively stable, fluctuating between approximately $23 billion and $28 billion, with a slight decreasing trend from 2021 onwards, possibly reflecting debt retirement or refinancing activities.
Deferred income taxes and Accrued pension/postretirement costs
Deferred income taxes decline steadily over time from over $5.3 billion in 2019 to around $3.2 billion in 2024, signaling decreasing deferred tax liabilities or changes in tax position. Accrued pension and postretirement health care costs decrease significantly post-2020, with health care costs decreasing from nearly $1.95 billion to approximately $1.09 billion, indicating possible cost management or changes in actuarial assumptions.
Stockholders’ equity and related components
Stockholders' equity attributable to the company declines sharply from $14 billion in early 2019 to a deficit position in late 2021 through 2023, reaching approximately negative $5 billion at one point before some improvement. This reflects a deterioration in net equity possibly due to accumulated losses, share repurchases, or other equity-reducing transactions. Additional paid-in capital remains generally stable, while earnings reinvested in the business show a decreasing pattern from above $43 billion to roughly $34 billion. Accumulated other comprehensive losses fluctuate but trend towards reduced losses in the mid-period, then increase again in recent quarters.
Cost of repurchased stock
This item reflects continuous accumulation of stock repurchases, increasing in absolute value from approximately $33.7 billion to over $41.8 billion during the timeframe, indicating significant buyback activity influencing the equity position.
Total liabilities and stockholders’ equity
The sum of total liabilities and stockholders’ equity declines steadily from nearly $59.2 billion in early 2019 to approximately $34.2 billion in late 2024, indicating a contraction in the overall balance sheet size, potentially driven by asset sales, debt repayments, or other restructuring events.

Overall, the financial data depicts a company managing significant debt obligations with fluctuating current liabilities and a shrinking equity base affected by ongoing share repurchases and variable earnings retention. Marketing spend steadily increases, reflecting a strategic focus on brand investment, while large settlement charges and other financial obligations exhibit considerable variability, implying episodic financial impacts. The recognition of deferred gains related to the IQOS System commercialization in later periods adds a substantial non-recurring financial element. A contraction in the total balance sheet size is evident from 2019 through 2024, possibly a result of deliberate financial restructuring measures.